Independent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 in human endometrial stromal cells by gonadotropin-releasing hormone: Implications in early human implantation

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 636-642

  Raga, Francisco ^a,b,d   Casañ, Eva Maria ^a,b   Wen, Yan ^a   Huang, Hong Yuan ^a,c   Bonilla Musoles, Fernando ^b   Polan, Mary Lake ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d Center for Gynecology and Obstetrics   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DETIRELIX; GELATINASE B; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HISTRELIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; ARTICLE; CONTROLLED STUDY; DECIDUA; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; NIDATION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STROMA CELL; TROPHOBLAST;

ADULT; BLOTTING, WESTERN; COLLAGENASES; CULTURE MEDIA, CONDITIONED; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; MATRIX METALLOPROTEINASE 9; POLYMERASE CHAIN REACTION; PREGNANCY; PROLACTIN; RNA, MESSENGER; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 0032979298     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.2.636     Document Type: Article

References (57)

1. 1. Ghosh D, Sengupta J. 1998 Recent developments in endocrinology and paracrinology of blastocyst implantation in the primate. Hum Reprod Update. 4:153-168.
2. 2. Cross JC, Werb Z, Fisher SJ. 1994 Implantation and the placenta; key pieces of the developmental puzzle. Science. 266:1508-1518.
3. 3. Timpl R. 1989 Structure and biological activity of basement membrane proteins. Eur J Biochem. 180:487-502.
4. 4 Birkedal-Hansen H, Moor WGI, Bodden MK, et al. 1993 Matrix metalloproteinase: a review. Crit Rev Oral Biol Med. 4:197-250.
5. 5. Woessner JF. 1991 Matrix metalloproteinase and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154.
6. 6. Docherty A, Murphy G. 1990 The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis. 51:469-479.
7. 7. Jeziorska M, Nagase H, Salamonsen LA, Woolley DE. 1996 Immunolocalization of the matrix metalloproteinase gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil. 107:43-51.
8. 8. Bischof P, Friedli E, Martelli M, Campana A. 1991 Expression of extracellular matrix-degrading metalloproteinases by cultured human cytotrophoblast cells: effects of cell adhesion and immunopurification. Am J Obstet Gynecot. 165:1791-1801.
9. 9. Librach CL, Werb Z, Fitzgerald ML, et al. 1991 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 113:437-449.
10. 10. Strickland S, Richards WG. 1992 Invasion of trophoblast. Cell. 71:355-357.
11. 11. Zhang J, Salamonsen LA. 1997 Tissue inhibitor of metalloproteinase (TIMP)-1, -2, and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod. 3:735-741.
12. 12. Goldberg GI, Strongin A, Collier IE, et al. 1992 Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimeriation, complex formation with interstitial collagenase and activation of the proenzime with stromelysin. J Biol Chem. 267:4583-4591.
13. 13. Welgus HG, Stricklin GP. 1983 Human skin fibroblast collagenase inhibitor. J Biol Chem. 258:12259-12264.
14. 14. Stetler-stevenson WG, Krutzsch HC, Liotta LA. 1989 Tissue inhibitor of metalloproteinase (TIMP-2), J Biol Chem. 264:17374-17378.
15. 15. Goldberg GI, Marner BL, Grant GA, et al. 1989 Human 72k type IV collagenase forms a complex with a tissue inhibitor of metalloproteinase designated TIMP-2. Proc Natl Acad Sci USA. 8207-8211.
16. 16. Blenis J, Hawkes SP. 1984 Characterization of a transforming-sensitive protein in the extracellular matrix of chicken embryo fibroblast. J Biol Chem. 259:11563-11570.
17. 17. Leco KJ, Khokha R, Pavloff N, et al. 1994 Tissue inhibitor of meteiloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem. 269:9352-9360.
18. 18. Apte S, Olsen BR, Murphy G. 1995 The gene structure of tissue inhibitor of metalloproteinases {TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem. 270:14313-14318.
19. 19. Greene J, Wang M, Liu YE, et al. 1996 Molecular cloning and characterization of tissue inhibitor of metalloproteinase 4. J Biol Chem. 271:30375-30380.
20. 20. Hurskainen T, Hoyhtya M, Tuuttila A, Oikarinen A, Autio-Harmainen H. 1996 mRNA expression of TIMP-1, -2, and -3 and 92-kD type IV collagenase in early human placenta and deciduai membrane as studies by in situ hybridization. J Histochem Cytochem. 44:1379-1388.
21. 21. Khodr GS, Siler-Khodr TM. 1980 Placental LRF and its synthesis. Science. 207:315-317.
22. 22. Imai A, Furui T, Tamaya T. 1992 Is extrapituitary action of gonadotropin releasing hormone biologically significant? Ann Clin Biochem. 29:477-480.
23. 23. Hsueh AJW, Jones PBC. 1981 Extrapituitary actions of gonadotropin releasing hormone. Endocr Rev. 2:437-455.
24. 24. Lee JN, Seppala M, Chard T. 1981 Characterization of placental luteinizing hormone releasing factor-like material. Acta Endocrinol (Copenh). 96:394-397.
25. 25. Seppala M, Wahistrom T, Lehtovirta P, Lee JN, Leppalouto J. 1980 Immunohistochemical demonstration of luteinizing hormone-releasing factor-like material in human syncytiotrophoblast, and trophoblastic tumors. Clin Endocrinol (Oxf). 12:441-451.
26. 26. Prager D, Weber MM, Herman-Bonert V. 1992 Placental growth factors and releasing/inhibiting peptides. Semin Reprod Endocrinol. 10:83-91.
27. 27. Lin L, Roberts VJ, Yen S. 1995 Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab. 80:580-585.
28. 28. Seshagiri PB, Terasawa E, Hearn JP. 1994 The secretion of gonadotrophin-releasing hormone by peri-implantation embryos of the rhesus monkey: comparison with the secretion of chorionic gonadotrophin. Hum Reprod. 9:1300-1307.
29. 29. Raga F, Casañ EM, Kruessel JS, et al. 1998 The role of Gonadotropin-releasing hormone (GnRH) in murine preimplantation embryonic development. Hum Reprod. 13:56.
30. 30. Raga F, Casañ EM, Ruiz A, et al. 1998 Gonadotropin-releasing hormone agonist (GnRH-a) administered throughout the luteal phase and early pregnancy increases fecundity in IVF-ET patients. Hum Reprod. 13:93.
31. 31. Pahwa Gs, Kullander S, Vollmer G, et al. 1991 Specific low affinity binding sites for Gonadotropin releasing hormone in human endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 41:135-142.
32. 6]-luteinizing hormone releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res. 50:1841-1846.
33. 33. Emons G, Schroder B, Ortmann O, et al. 1993 High affinity binding and direct antiproliferative effects of luteinizing hormone releasing hormone analogs in human endometrial cancer lines. J Clin Endocrinol Metab. 77:1458-1464.
34. 34. Casañ EM, Raga F, Kruessel JS, et al. 1998 Immunoreactive Gonadotropin-releasing hormone (GnRH) expression in cycling human endometrium of fertile patients. Fertil Steril. 70:102-106.
35. 35. Raga F, Casañ EM, Krüssel JS, et al. 1998 Quantitative gonadotropin-releasing hormone (GnRH) gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod. 59: 661-669.
36. 36. Huang H, Wen Y, Irwin JC, et al. 1998 Cytokine-mediated regulation of 92 kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab. 83:1721-1729.
37. 37. Simon C, Piquette GN, Frances A, Polan ML. 1993 Localization of interleukin-1 type I receptor and interleukin-1β in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab. 77:549-555.
38. 38. Wilhelm SM, Collier IE, Marmer BL, et al. 1989 SV40-transformed human lung fibroblast secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophage. J Biol Chem. 264:17213-17221.
39. 39. Opbroek A, Kenney MC, Brown D. 1993 Characterization of a human corneal metalloproteinase inhibitor (TIMP-1). Curr Eye Res. 12:877-883.
40. 40. Byrne JA, Tomasetto C, Rouyer N, et al. 1995 The tissue inhibitior of metalloproteinases-3 gene in breast carcinima: identification of multiple polyadenylation sites and a stromal pattern of expression. Mol Med. 1:418-427.
41. 41. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. 1984 Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res. 12:1687-1696.
42. 42. Jin CF, Mata M, Fink DJ. 1994 Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PR Methods Applic. 3:252-255.
43. 43. Eickelberg O, Sommerfeld CO, Wyser C, et al. 1997 MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med. 156:1987-1992.
44. 44. Simon C, Gimeno MJ, Mercader A, et al. 1996 Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link in embryonic implantation? Mol Hum Reprod. 2:405-424.
45. 45. Khodr GS, Siler-Khodr TM. 1980 Placental LRF and its synthesis. Science. 207:315-317.
46. 46. Imai A, Furui T, Tamaya T. 1992 Is extrapituitary action of gonadotropin releasing hormone biologically significant?. Ann Clin Biochem. 29:477-480.
47. 47. Siler-Khodr TM, Khodr GS. 1978 Luteinizing hormone releasing factor content of the human placenta. Am J Obstet Gynecol. 130:216-219.
48. 48. Prager D, Weber MM, Herman-Bonert V. 1992 Placental growth factors and releasing/inhibiting peptides. Semin Reprod Endocrinol. 10:83-91.
49. 49. Lin L, Roberts VJ, Yen S. 1995 Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab. 80:580-585.
50. 50. Casañ EM, Raga F, Polan ML. Gonadotrophin-releasing hormone mRNA and protein expression in preimplantation human embryos. Mol Hum Reprod. In press.
51. 51. Gordon K, Williams RF, Danforth DT, Hodgen GD. 1990 A novel regimen of gonadotropin-releasing hormone (GnRH) antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction. Fertil Steril. 54:1140-1145.
52. 52. Rodgers WH, Matrisian LM, Giudice LC, et al. 1994 Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulations by steroid hormones. J Clin Invest. 94:946-953.
53. 53. Dou Q, Tarnuzzer RW, Williams RS, Schultz GS, Chegini N. 1997 Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyoma: a mechanism for gonadotropin releasing hormone agonistinduced tumour regression. Mol Hum Reprod. 3:1005-1014.
54. 54. Takeuchi S, Futamura N, Minoura H, Toyoda N. 1998 Possible direct effect of gonadotropin-releasing hormone on human endometrium and decidua. Life Sci. 62:1187-1194.
55. 55. Balasch J, Martinez F, Jové I, et al. 1993 Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod. 8:1148-1151.
56. 56. Diviacco S, Norio P, Zentilin L, et al. 1992 A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Genes. 122:3013-3020.
57. 57. Souzé F, Ntodou-Thomé A, Cy T, et al. 1996 Quantitative RT-PCR: limits and accuracy. BioTechniques. 21:280-285.